| abstract |
Compounds with medicinal and bioavailability properties, their pharmaceutical compositions and methods of application are considered. In particular, C-17 and C-3 modified triterpenoids, which have unique antiviral activity, are described as HIV maturation inhibitors, which are represented by compounds of formulas I, II and III. These compounds are suitable for the treatment of HIV and AIDS. |